In addition to understanding basic AMPK biology, these mouse models can serve as preclinical tools for testing and developing drugs for metabolic diseases that can selectively target AMPK in specific tissues or cellular contexts to minimize potential side effects. The gene discussed is PRKAA2; the disease is Other metabolic disease.